Finance

Beta
Lists
900904:SHA
Shanghai Shenqi Pharmaceutical Investment Management Ord Shs B
$0.42
+0.72%
(+0.0030) 1D
Jun 17, 3:00:00 PM GMT+8  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for 900904...
Open
$0.42
High
$0.43
Low
$0.41
Mkt. cap
2.52B
Avg. vol.
64.12K
Volume
37.20K
Dividend
16.59%
Quarterly dividend
$0.02
Ex-dividend date
Jun 17, 2026
P/E ratio
6.24
52-wk high
$0.59
52-wk low
$0.41
EPS
$0.07
Shares outstanding
54.75M
No. of employees
1K
Open
$0.42
High
$0.43
Low
$0.41
Mkt. cap
2.52B
Avg. vol.
64.12K
Volume
37.20K
Dividend
16.59%
Quarterly dividend
$0.02
Ex-dividend date
Jun 17, 2026
P/E ratio
6.24
52-wk high
$0.59
52-wk low
$0.41
EPS
$0.07
Shares outstanding
54.75M
No. of employees
1K
News stories
From sources across the web
About Shanghai Shenqi Pharmaceutical Investment Management Ord Shs B
CEO-
Employees1.2K
Founded1990
Headquarters-
SectorPharmaceutical industry
Websitegzsq.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
480.92M
437.01M
554.51M
422.94M
Cost of goods sold
263.32M
221.29M
348.47M
232.06M
Cost of revenue
263.32M
221.29M
348.47M
232.06M
Research and development expenses
6.19M
7.91M
8.48M
7.04M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
180.95M
169.03M
186.17M
148.02M
Operating expense
194.66M
185.83M
211.87M
169.08M
Total operating expenses
457.99M
407.11M
560.34M
401.14M
Operating income
22.94M
29.90M
-5.83M
21.80M
Other non operating income
285.70K
-1.06M
-1.07M
-1.84M
EBT including unusual items
25.30M
19.70M
5.71M
19.41M
EBT excluding unusual items
23.14M
29.63M
-5.90M
19.66M
Income tax expense
6.60M
3.03M
16.97M
7.38M
Effective tax rate
26.10%
15.36%
296.96%
38.03%
Other operating expenses
5.21M
8.98M
3.52M
9.92M
Net income
17.81M
17.49M
-12.06M
12.88M
Net profit margin
3.70%
4.00%
-2.17%
3.05%
Earnings per share
-
-
-
-
Interest and investment income
3.33M
1.85M
4.08M
2.07M
Interest expense
-3.42M
-1.07M
-3.10M
-2.37M
Net interest expenses
-84.80K
783.54K
983.79K
-305.41K
Depreciation and amortization charges
-
-
-
-
EBITDA
40.05M
49.34M
12.75M
40.38M
Gain or loss from assets sale
-
-
-227.96K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer